£1 million award for BactiVac network to continue supporting development of bacterial vaccines
22 February 2023
Bacterial infections kill over 7 million people each year and the development of new and better vaccines will reduce this devastating burden of disease.
BactiVac, the Bacterial Vaccines Network, has secured £1 million of funding from Wellcome to accelerate the development of bacterial vaccines and combat the threat of antimicrobial resistance (AMR).
Further reading: University of Birmingham
Author(s): University of Birmingham
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
LifeArc |
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
AMR NEWS
Every two weeks in your inbox
Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!